Abstract
The designation of atherosclerosis as a chronic inflammatory process represents an exciting and logical paradigm shift for cardiologists. Plasma concentrations of interleukin‐6 (IL‐6) and its hepatic by‐product C‐reactive protein (CRP) appear to reflect the intensity of occult plaque inflammation and by inference may determine vulnerability to rupture. Indeed, circulating IL‐6 levels are elevated in patients with acute myocardial infarction (AMI), and also in patients with unstable, but not with stable angina. Coronary sinus IL‐6 concentrations are also increased after percutaneous coronary intervention (PCI), and late restenosis correlates with an increase in IL‐6 concentration after the procedure, indicating that IL‐6 expression may be not only related to instability of atheromatous plaques, but also to the formation of restenotic lesions after PCI. These observations suggest the advantage of screening for circulating IL‐6 concentration and the use of anti‐inflammatory treatment for those thought be at high risk to reduce the risk of future AMI.
Keywords: myocardial infarction, angina pectoris, restenosis, cytokine, inflammation
Full Text
The Full Text of this article is available as a PDF (379.2 KB).
References
- 1. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A: Effect of human recombinant interleukin‐6 and interleukin‐8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997; 17: 3399–3405 [DOI] [PubMed] [Google Scholar]
- 2. Hamanak R, Kohno K, Seguchi T, Okamura K, Morimoto T, Onon M, Ogata M, Kuwano M: Induction of low‐density lipoprotein receptor and transcription factor SP‐1 by tumor necrosis factor in human vascular endothelial cells. J Biol Chem 1992; 267: 13160–13165 [PubMed] [Google Scholar]
- 3. Galis ZS, Muszynski M, Sukhova GK, Simon‐Morrissey E, Unemori EN, Lark M, Amento E, Libby P: Cytokine‐stimulated smooth muscle cells stimulate a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75: 181–189 [DOI] [PubMed] [Google Scholar]
- 4. Biswas P, Delfanti F, Mengozzi M, Cota M, Polentarutti N, Matnovani A, Lazzarin A, Sozzani S, Poli G: Interleukin 6 induces monocyte chemotactic protein‐1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998; 91: 258–265 [PubMed] [Google Scholar]
- 5. Ikeda U, Ikeda M, Seino Y, Takahashi M, Kasahara T, Kano S, Shimada K: Expression of intracellular adhesion molecule 1 in rat vascular smooth muscle cells by pro‐inflammatory cytokines. Atherosclerosis 1993; 104: 61–68 [DOI] [PubMed] [Google Scholar]
- 6. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S: Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF‐dependent manner. Am J Physiol 1991; 260: H1713–H1717 [DOI] [PubMed] [Google Scholar]
- 7. Montavi A: The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs 1997; 97 (suppl I): 15–23 [DOI] [PubMed] [Google Scholar]
- 8. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, Altamura S, Ciliberto G, Rebuzzi AG, Crea F, Pepys MB, Maseri A: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370–2376 [DOI] [PubMed] [Google Scholar]
- 9. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group : Production of C‐reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462–466 [DOI] [PubMed] [Google Scholar]
- 10. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992; 24: 579–584 [DOI] [PubMed] [Google Scholar]
- 11. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RR, Sanders GT: Interleukin‐6 release and the acute‐phase reaction in patients with acute myocardial infarction: A pilot study. J Lab Clin Med 1992; 119: 574–579 [PubMed] [Google Scholar]
- 12. Seino Y, Ikeda U, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K: Interleukin‐6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994; 6: 87–91 [DOI] [PubMed] [Google Scholar]
- 13. Rus HG, Vlaicu R, Niculescu F: Interleukin‐6 and interleukin‐8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263–271 [DOI] [PubMed] [Google Scholar]
- 14. Kaneko K, Kanda T, Yokoyama T, Nakazato Y, Iwasaki T, Kobayashi I, Nagai R: Expression of interleukin‐6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol 1997; 97: 3–12 [PubMed] [Google Scholar]
- 15. Schieffer B, Schieffer E, Hilfiker‐Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 2000; 101: 1372–1378 [DOI] [PubMed] [Google Scholar]
- 16. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML: Cardiac myocytes produce interleukin‐6 in culture and in viable border zone of reperfused infarctions. Circulation 1999; 99: 546–551 [DOI] [PubMed] [Google Scholar]
- 17. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, Ottini E, Mussini A, Specchia G: Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 1999; 145: 369–374 [DOI] [PubMed] [Google Scholar]
- 18. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE: Circulating levels of IL‐1 beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis 2000; 9: 217–222 [DOI] [PubMed] [Google Scholar]
- 19. Manten A, de Winter RJ, Minnema MC, ten Cate H, Lijmer JG, Adams R, Peters RJ, van Deventer SJ: Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res 1998; 40: 389–395 [DOI] [PubMed] [Google Scholar]
- 20. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A: Increasing levels of interleukin (IL)‐1 Ra and IL‐6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in‐hospital coronary events. Circulation 1999; 99: 2079–2084 [DOI] [PubMed] [Google Scholar]
- 21. Yazdani S, Simon AD, Vidhun R. Gulotta C, Schwartz A, Rabbani LE: Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am Heart J 1998; 136: 357–361 [DOI] [PubMed] [Google Scholar]
- 22. Suzuki T, Ishiwata S, Hasegawa K, Yamamoto K, Yamazaki T: Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis. Heart 2000; 83: 578 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K: Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000; 84: 83–87 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin‐6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–1772 [DOI] [PubMed] [Google Scholar]
- 25. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin‐6 in unstable angina. Circulation 1996; 94: 874–877 [DOI] [PubMed] [Google Scholar]
- 26. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepus MB, Maseri A: The prognostic value of C‐reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417–424 [DOI] [PubMed] [Google Scholar]
- 27. Ridker PM, Cushman M, Stampfer MI, Tracy RP, Hennekens CH: Production of C‐reactive protein and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–979 [DOI] [PubMed] [Google Scholar]
- 28. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moyé LA, Goldman S, Flaker GC, Braunwald E: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients widi average cholesterol levels. Circulation 1998; 98: 839–844 [DOI] [PubMed] [Google Scholar]
- 29. Vaughan CJ, Murphy MB, Buckley BM: Statins do more than just lower cholesterol. Lancet 1996; 348: 1079–1082 [DOI] [PubMed] [Google Scholar]
- 30. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P: Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793–798 [DOI] [PubMed] [Google Scholar]
- 31. Ikeda U, Ito T, Shimada K: Statins and C‐reactive protein. Lancet 1999; 353: 1274–1275 [DOI] [PubMed] [Google Scholar]
- 32. Inoue I, Goto S, Mizotani K, Awata T, Matsunaga T, Kawai S, Nakajima T, Hokari S, Komoda T, Katayama S: Lipophilic HMG‐CoA reductase inhibitor has an anti‐inflammatory effect: Reduction of mRNA levels for interleukin‐Iβ, interleukin 6, cyclooxygenase‐2, and p22phox by regulation of peroxisome proliferator‐activated receptor α (PPARα) in primary endothelial cells. Life Sci 2000; 67: 863–876 [DOI] [PubMed] [Google Scholar]
- 33. Bickel C, Rupprecht HJ, Blankenberg S, Hafner G, Rippin G, Meyer J: Non‐lipid lowering effects of statin medication in patients with coronary heart disease (abstr). J Am Coll Cardiol 2000; 35: 256A [Google Scholar]